Symptoms like nausea, fatigue, reflux and other gastrointestinal symptoms are common during the early weeks of treatment and after dose increases
Research on intranasal peptide delivery indicates that molecules up to approximately 6000 Da can be absorbed, placing TB-500 within range but potentially at lower efficiency than smaller peptides like BPC-157
Convenience is higher, but penetration and systemic effects are limited
Heres a chart, based on data from this study: People with obesity or metabolic syndrome have chronically high GLP-1 levels, possibly because the diet that tends to cause obesity and metabolic syndrome is high in sugar and simple carbs, which raise blood sugar and demand a lot of GLP-1
LIV Body describes compounded tirzepatide as the "Advanced Option," with a brand-stated starting price of $279/month
Consider using other tools to improve patient, household, and community safety, such as patient-prescriber agreements that reinforce patient-prescriber responsibilities
